Cold virus engineered to attack pancreatic cancer shows promise in early trial
Disease control
Completed
This study tested a modified cold virus called LOAd703 in 51 people with pancreatic cancer. The virus is designed to infect and kill cancer cells while also boosting the immune system. It was given alongside standard chemotherapy, and in some cases an immunotherapy drug, to see i…
Phase: PHASE1, PHASE2 • Sponsor: Lokon Pharma AB • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC